MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Magnitude of Non-Motor Symptoms Among People with Parkinson’s Disease in Rural and Urban Tanzania

    B. Mushengezi, K. Okeng'O, R. Walker, M. Mng'Ong'O, E. Massawe, M. Dekker, N. Okubadejo, P. Adebayo, N. Fothergill-Misbah, Y. Okkaoglu, S. Urasa (Dar es Salaam, United Republic of Tanzania)

    Objective: We aimed to determine the prevalence of non-motor symptoms in people with Parkinson’s disease. Background: Parkinson’s disease is the second most common neurodegenerative disease…
  • 2026 International Congress

    Improvement of Wearing‑Off Symptoms After Initiation of COMT Inhibitors in Parkinson’s Disease patients with early motor fluctuations: Results from the 12 months interim analysis of REONPARK Study

    L. López-Manzanares, M. Cerdán, I. Gaston, R. Vázquez, B. Vives, M. Carmona, M. Rodriguez-de Miguel, I. Tegel, D. Magalhāes, J. Holenz (Madrid, Spain)

    Objective: The REONPARK study is an observational study conducted in Spain aiming to evaluate COMT inhibitors (iCOMT) effectiveness and tolerability in alleviating motor complications associated…
  • 2026 International Congress

    The association of low back pain-related disability with functional mobility among individuals with Parkinson disease in Sri Lanka.

    YS. Thakshila, HHN. Kalyani (Colombo, Sri Lanka)

    Objective: This study aimed to examine the association between low back pain (LBP) related disability and functional mobility in individuals with Parkinson disease (PD). Background:…
  • 2026 International Congress

    Heterogeneous Responsiveness to Combined Motor–Cognitive Exercise in Parkinson’s Disease: A Latent Class Analysis

    J. Hwang, C. Youm, H. Park, M. Kim, B. Kim, S. Cheon (busan, Republic of Korea)

    Objective: To evaluate the effects of a combined motor–cognitive exercise intervention in individuals with Parkinson’s disease (PD) and to explore latent response subgroups to identify…
  • 2026 International Congress

    Specific thalamic subnuclei volumes associate with autonomic dysfunction in Parkinson’s disease

    S. Haji, W. Sako, K. Takabayashi, K. Kamagata, T. Hatano, N. Hattori (Bunkyo-ku, Japan)

    Objective: To elucidate the association between autonomic symptoms and Parkinson’s disease (PD) subgroups stratified by k-means clustering of thalamic subnuclear volumes measured by MRI. Background:…
  • 2026 International Congress

    White Matter Hyperintensity and the Spatial Subtypes in Parkinson’s Disease

    XY. Xie, HL. Wang, YL. Du, G. Wang (Shanghai, China)

    Objective: To determine whether white matter hyperintensity (WMH) volume and its spatial subtypes, periventricular WMH (PWMH) and deep WMH (DWMH), are associated with cognitive impairment…
  • 2026 International Congress

    Genetic analysis of the X chromosome and Parkinson’s disease

    N. Kuznetsov, M. Makarious, K. Levine, D. Vitale, C. Blauwendraat, A. Singleton, H. Leonard (Washington, USA)

    Objective: To investigate chromosome X genetic risk factors for Parkinson’s disease (PD) across European and Ashkenazi Jewish ancestries and establish a robust framework for X-chromosome…
  • 2026 International Congress

    The Association between Antiepileptic Drug Use, Epilepsy and the Risk of Parkinson’s Disease: A Systematic Review and Meta-analysis

    RG. Mohamed, O. Yousef (Mansoura, Egypt)

    Objective: To assess the relationship between epilepsy, antiepileptic drug use, and Parkinson's disease Background: Parkinson's disease (PD) is a progressive neurodegenerative disorder with multiple risk…
  • 2026 International Congress

    Neuromelanin Loss Is Associated with Increased Substantia Nigra Free-Water: a Longitudinal Study of Controls, RBD, and PD

    V. Madge, K. Wennberg, R. Klevor, A. Dagher, R. Postuma, D L. Collins (Montréal, Canada)

    Objective: To longitudinally characterize substantia nigra (SN) neuromelanin (NM) and free-water (FW) MRI biomarkers by comparing control, REM sleep behaviour disorder (RBD), and Parkinson’s disease…
  • 2026 International Congress

    Reasons and Factors Influencing Parkinson’s Patients’ Decision to Decline Deep Brain Stimulation

    L. Cabrera, H. King, L. Al Damluji, J. Blumenthal-Barby, B. Levi, S. de Jesus (University Park, USA)

    Objective: To investigate reasons and factors influencing Parkinson’s patients’ decision to decline deep brain stimulation (DBS). Background: While much research has focused on patients with…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley